To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma

Peter Martin, Andre Goy, Radhakrishnan Ramchandren, Lucille Ferrante, Anil Londhe, Tracy McGowan, Nancy L. Bartlett

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)1027-1030
Number of pages4
JournalJournal of Oncology Pharmacy Practice
Issue number4
StatePublished - Jun 1 2019

Cite this